Dr. Friedman is currently investigating novel nanotechnologies that allow for controlled and sustained delivery of a wide spectrum of physiologically and medicinally relevant molecules, with an emphasis on treating infectious diseases, accelerating wound healing, immune modulation, and correcting vascular dysfunction. He holds several patents derived from these investigations, and has published over 90 papers/chapters and two textbooks. He has received awards from multiple organizations, including the American Academy of Dermatology, American Society for Dermatologic Surgery, Dermatology Foundation, and the La Roche Posay North American Foundation.